Post-CABG Mediastinitis

1. Executive Overview: Understanding Post-CABG Mediastinitis

Post-CABG Mediastinitis, clinically classified under ICD-10 code T81.4XXA (Infection following a procedure, superficial incisional surgical site), represents one of the most feared and complex complications following Coronary Artery Bypass Grafting (CABG). It is defined as a deep-seated infection of the mediastinum—the central compartment of the thoracic cavity containing the heart, great vessels, and esophagus—that occurs following a median sternotomy.

While modern surgical techniques and prophylactic antibiotic protocols have reduced the incidence of mediastinitis to approximately 1% to 3% of all CABG procedures, the condition remains a critical clinical emergency. It is associated with significant morbidity, prolonged hospitalization, and a mortality rate that can range from 10% to 40% if not addressed with aggressive, multidisciplinary intervention. As specialists in reconstructive plastic surgery, our role is often the final tier of defense, utilizing advanced tissue transfer techniques to achieve obliteration of the infected space and restoration of chest wall integrity.

2. Pathophysiology, Etiology, and Risk Factors

The Pathophysiological Cascade

The development of mediastinitis is rarely the result of a single event; rather, it is a multifactorial breakdown of the sternal healing process. The pathophysiology begins with the introduction of microorganisms—most commonly Staphylococcus aureus or Staphylococcus epidermidis—into the retrosternal space during or immediately after surgery.

Once bacteria colonize the mediastinal space, the lack of natural drainage and the presence of foreign bodies (such as sternal wires or graft material) facilitate the formation of a biofilm. This biofilm protects the bacteria from systemic antibiotic therapy and host immune responses, leading to sternal osteomyelitis and tissue necrosis.

Etiology and Risk Factors

Risk factors are broadly categorized into preoperative, intraoperative, and postoperative variables.

The use of bilateral internal mammary arteries (BIMA) is a known contributor to compromised blood supply to the sternum, significantly increasing the risk of sternal non-union and subsequent infection.

3. Signs, Symptoms, and Clinical Presentation

Early detection is paramount. Patients may present with subtle clinical markers that rapidly progress to systemic sepsis.

• Local Signs: Erythema (redness) along the surgical incision, localized warmth, edema, and purulent discharge from the sternal wound.
• Sternal Instability: A "clicking" sensation or palpable movement of the sternum during respiration or movement is a pathognomonic sign of sternal dehiscence and deep infection.
• Systemic Symptoms: Unexplained fever, tachycardia, leukocytosis, and hemodynamic instability.
• The "Silent" Presentation: In diabetic or elderly patients, classic inflammatory signs may be muted. Any patient showing persistent "failure to thrive" or unexplained malaise in the weeks post-CABG must be evaluated for deep sternal wound infection (DSWI).

4. Standard Diagnostic Evaluation & Workup

Diagnosis is clinical but must be corroborated by imaging and laboratory assays to determine the extent of the involvement.

Diagnostic Workup Protocols

1. Laboratory Assays: Complete blood count (CBC) to assess for leukocytosis, inflammatory markers (C-reactive protein [CRP] and erythrocyte sedimentation rate [ESR]), and serial blood cultures to rule out systemic bacteremia.
2. Imaging:
   • Chest X-ray: Often shows wire loosening or retrosternal air-fluid levels.
   • Computed Tomography (CT) Scan: The gold standard. A CT with contrast will demonstrate mediastinal fluid collections, sternal dehiscence, and inflammatory changes in the retrosternal fat.
3. Microbiological Analysis: Deep tissue cultures obtained via surgical debridement are superior to superficial swab cultures, which are often contaminated by skin flora.

5. Therapeutic Interventions

Management is a two-pronged approach: source control through surgical debridement and systemic management through targeted antimicrobial therapy.

Surgical Management (The Plastic Surgery Perspective)

The cornerstone of treatment is aggressive surgical debridement of all necrotic bone and infected mediastinal tissue. Once the infection is cleared, the plastic surgeon’s goal is "dead space" management.

• Negative Pressure Wound Therapy (NPWT): Often used as a bridge to therapy to promote granulation tissue and reduce bacterial load.
• Muscle Flaps: The gold standard for reconstruction. The Pectoralis Major muscle (unilateral or bilateral) is typically mobilized and rotated to obliterate the mediastinal defect, providing vascularized tissue to fight residual infection and promote healing.
• Omental Flaps: Used in cases of severe or recurrent mediastinitis where the pectoralis muscle is insufficient. The omentum is brought up through the diaphragm for its superior angiogenic and immunological properties.

Pharmacotherapy

Empiric antibiotic therapy should be initiated immediately after cultures are taken, typically covering Gram-positive organisms (Vancomycin) and Gram-negative bacilli (Cefepime or Piperacillin/Tazobactam). Therapy is refined based on the final sensitivity reports from the surgical biopsy.

6. Frequently Asked Questions (FAQ)

1. Is Post-CABG Mediastinitis always fatal?
No. While it is a serious complication, modern surgical debridement and advanced plastic surgery techniques have significantly improved survival rates.

2. How long after surgery does mediastinitis typically appear?
It usually presents within the first 2 to 3 weeks post-operatively, but delayed presentations can occur up to several months later.

3. What is the role of a plastic surgeon in this condition?
The plastic surgeon is responsible for the definitive closure of the chest wall. We use vascularized muscle or omental flaps to fill the cavity, which provides the blood supply necessary to heal the infection.

4. Can I prevent mediastinitis before my CABG?
Optimizing glycemic control, smoking cessation, and maintaining a healthy weight significantly reduce your risk profile before surgery.

5. Is sternal "clicking" normal after heart surgery?
No. Sternal clicking indicates instability of the sternal wires or bone. You must contact your surgical team immediately if you experience this.

6. Will I need another heart surgery to fix the infection?
The infection is "outside" the heart, but it involves the chest wall. The procedure involves opening the chest, removing infected tissue, and closing it again. It is a major surgical procedure.

7. How effective are muscle flaps?
Muscle flaps are highly effective because they bring healthy, oxygenated blood and immune cells directly into the infected area, which bone and cartilage lack.

8. Is there a risk of the infection returning?
With adequate debridement and successful flap coverage, the recurrence rate is low. However, patients with compromised immune systems remain at higher risk.

9. How long does the recovery process take?
Recovery is individualized, but it typically involves several weeks of intravenous antibiotics followed by a period of wound healing and physical rehabilitation.

10. What diagnostic test is the most accurate?
A CT scan of the chest is considered the gold standard for diagnosing the extent of mediastinal involvement and sternal dehiscence.

Disclaimer: This guide is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always seek the advice of your cardiothoracic surgeon or plastic reconstructive surgeon regarding any medical condition.